Bullish Stock Trend Analysis: National Bank of Greece, Microsoft Corporation, Aetrium, Echo Therapeutics, Twitter Inc

NEW YORK, December 2, 2013 /PRNewswire/ --

Market Buzz Report, engaged in providing penny stock alerts, issues notable stock analysis for National Bank of Greece (NYSE: NBG), Microsoft Corporation (NASDAQ: MSFT), Aetrium, Inc. (NASDAQ: ATRM), Echo Therapeutics Inc (NASDAQ: ECTE), Twitter Inc (NYSE: TWTR).

National Bank of Greece (NYSE: NBG) shares climbed 6.27% to $6.27. The company on Nov. 25 said it has agreed to sell a majority stake in its real estate arm Pangaia to private equity firm Invel Real Estate in a 653 million-euro ($882 million) deal. The sale, which was revealed, last week, is part of a restructuring by National Bank (NBG) aimed at boosting its capital base.

Free Urgent Insider Catalyst Report For NBG Available Here:  http://marketbuzzreport.com/index.php?code=NBG  (Or Copy and paste the URL into your browser)

Under the terms of the latest deal Invel will acquire 66 percent of Pangaia, NBG said in a statement, and will pay 161 million in cash, contribute equity in the form of real estate and also take out a loan from NBG.

Microsoft Corporation (NASDAQ: MSFT) shares increased 1.41% to $38.13. The company on Nov. 19 announced that its board of directors declared a quarterly dividend of $0.28 per share.  The dividend is payable March 13, 2014 to shareholders of record on February 20, 2014.  The ex-dividend date will be February 18, 2014.

Free Urgent Insider Catalyst Report For MSFT Available Here:  http://marketbuzzreport.com/index.php?code=MSFT  (Or Copy and paste the URL into your browser)

Additionally, the company on Nov. 8 announced participation in the following upcoming events with the financial community. Interested parties can listen to a webcast of these events on Microsoft's Investor Relations website: UBS Global Technology Conference on Thursday, November 21, 2013 at 8:30 a.m. Pacific Time.

Shares of Aetrium, Inc. (NASDAQ: ATRM) surged 150% last week after SA contributor Small-Cap Momentum Advisors pens the bull case, arguing that shares should be valued at $15-$20.The author bases the thesis on a recent management shake-up that saw activist Jeffrey Eberwein appointed Chairman. Eberwein and his fund, Lone Star Investors, have a 5.6% stake in ATRM.Q1, the author says, "should be a monumental turnaround quarter," with the company booking revenues of a previously-announced $2.1M order by the quarter's end. The order alone represents almost 2x Q1 2013 revenue, and is indicative of "significant traction," the author notes.

Free Urgent Insider Catalyst Report For ATRM Available Here:  http://marketbuzzreport.com/index.php?code=ATRM  (Or Copy and paste the URL into your browser)

Shares of Echo Therapeutics Inc (NASDAQ: ECTE) soared nearly 65% to $3.83 last week following the release of positive results of its study on wireless glucose monitoring system, Symphony CGM. The study revealed that Symphony is capable of monitoring glucose levels as it did on 32 patients in critical care units at four hospitals. The Continuous Glucose-Error Grid Analysis showed that readings in Symphony CGM were 97.9% accurate and 1.8% were benign errors, with a combined A+B value of 99.7%.  The glucose values range was 49 to 324 mg/dL.

Free Urgent Insider Catalyst Report For ECTE Available Here:  http://marketbuzzreport.com/index.php?code=ECTE  (Or Copy and paste the URL into your browser)

Though still below its opening price of $45.10, Twitter Inc (NYSE: TWTR) has rallied 6% from its Monday close of $39.06. The gains come ahead of Monday coverage launches from the company's IPO underwriters. If history is any guide, bullish reports should easily outweigh bearish ones; the investor reaction might depend a lot on how upbeat analysts are in the face of a valuation that's still around ~40x 2013E sales (after factoring options/RSUs). Ahead of the launches, Twitter has picked up four bullish ratings, eight neutral ones, and three bearish ones non-underwriting firms. The neutral/bearish arguments almost uniformly revolve around Twitter's multiples. Wunderlich, which is reiterating a Sell, notes pre-IPO underwriter estimates were well below current consensus forecasts. The firm is reiterating a $34 PT, and maintaining a subdued view of Twitter's efforts to sell ads to TV advertisers and e-commerce firms.

Free Urgent Insider Catalyst Report For TWTR Available Here:  http://marketbuzzreport.com/index.php?code=TWTR  (Or Copy and paste the URL into your browser)

USMarketBuzz.com is an investment community that Focuses on MicroCap Securities. USMarketBuzz.com is an  authorative authentic Google News Site and Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit http://www.USMarketBuzz.com/ for more details. Get an edge on the market with our Premium News Alerts   that are FREE for a limited time at http://www.USMarketBuzz.com/. Follow us on Facebook: https://www.facebook.com/usmarket.buzz. Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126.  (SMS alerts are free, however data rates may apply, check your wireless plan for details.)

DISCLAIMER:  FNNewswire (FNNW) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNNW is NOT affiliated in any manner with MarketBuzz Reports, USMarketBuzz.com or any company mentioned herein.  The commentary, views and opinions expressed in this release by MarketBuzz Reports and USMarketBuzz.com are solely those of the MarketBuzz Reports & USMarketBuzz.com and are not shared by and do not reflect in any manner the views or opinions of FNNW. The companies that are discussed herein may or may not have approved the statements made in this release.  FNNW is not liable for any investment decisions by its readers or subscribers FNNW and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNNW was not compensated by any public company mentioned herein to disseminate this press release.

FNNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.  

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNNW undertakes no obligation to update such statements.

FNNW Contact Information:
Company: FN Newswire
Contact email: editor@fnnewswire.com
U.S. Phone: +1(954)345-0611

SOURCE FN Media Group LLC




Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.